These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 34366826)
21. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Chen Z; Zhong C Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509 [TBL] [Abstract][Full Text] [Related]
22. Immunotherapy for the treatment of Alzheimer's disease: amyloid-β or tau, which is the right target? Castillo-Carranza DL; Guerrero-Muñoz MJ; Kayed R Immunotargets Ther; 2014; 3():19-28. PubMed ID: 27471697 [TBL] [Abstract][Full Text] [Related]
23. Research Progress on the Etiology and Pathogenesis of Alzheimer's Disease from the Perspective of Chronic Stress. Liu YS; Zhao HF; Li Q; Cui HW; Huang GD Aging Dis; 2023 Aug; 14(4):1292-1310. PubMed ID: 37163426 [TBL] [Abstract][Full Text] [Related]
24. Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment. Qin Q; Li Y J Med Virol; 2019 Aug; 91(8):1368-1377. PubMed ID: 30997676 [TBL] [Abstract][Full Text] [Related]
28. Connecting the Dots: Linking the Biochemical to Morphological Transitions in Alzheimer's Disease. Baig AM ACS Chem Neurosci; 2019 Jan; 10(1):21-24. PubMed ID: 30160095 [TBL] [Abstract][Full Text] [Related]
29. Alzheimer's Disease, Inflammation, and the Role of Antioxidants. Sinyor B; Mineo J; Ochner C J Alzheimers Dis Rep; 2020 Jun; 4(1):175-183. PubMed ID: 32715278 [TBL] [Abstract][Full Text] [Related]
30. Amyloid precursor protein, presenilins, and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer's disease. Suh YH; Checler F Pharmacol Rev; 2002 Sep; 54(3):469-525. PubMed ID: 12223532 [TBL] [Abstract][Full Text] [Related]
31. The antimicrobial protection hypothesis of Alzheimer's disease. Moir RD; Lathe R; Tanzi RE Alzheimers Dement; 2018 Dec; 14(12):1602-1614. PubMed ID: 30314800 [TBL] [Abstract][Full Text] [Related]
33. Liraglutide Protects Against Brain Amyloid-β Duarte AI; Candeias E; Alves IN; Mena D; Silva DF; Machado NJ; Campos EJ; Santos MS; Oliveira CR; Moreira PI Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32143329 [TBL] [Abstract][Full Text] [Related]
34. The Early Events That Initiate β-Amyloid Aggregation in Alzheimer's Disease. Zhang X; Fu Z; Meng L; He M; Zhang Z Front Aging Neurosci; 2018; 10():359. PubMed ID: 30542277 [TBL] [Abstract][Full Text] [Related]
35. Learning from the Past: A Review of Clinical Trials Targeting Amyloid, Tau and Neuroinflammation in Alzheimer's Disease. Ceyzériat K; Zilli T; Millet P; Frisoni GB; Garibotto V; Tournier BB Curr Alzheimer Res; 2020; 17(2):112-125. PubMed ID: 32129164 [TBL] [Abstract][Full Text] [Related]
36. Periodontal Disease and Periodontal Disease-Related Bacteria Involved in the Pathogenesis of Alzheimer's Disease. Matsushita K; Yamada-Furukawa M; Kurosawa M; Shikama Y J Inflamm Res; 2020; 13():275-283. PubMed ID: 32636667 [TBL] [Abstract][Full Text] [Related]
37. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. Pulliam L; Sun B; Mustapic M; Chawla S; Kapogiannis D J Neurovirol; 2019 Oct; 25(5):702-709. PubMed ID: 30610738 [TBL] [Abstract][Full Text] [Related]
38. Amelioration of Alzheimer's disease pathology and cognitive deficits by immunomodulatory agents in animal models of Alzheimer's disease. Martinez B; Peplow PV Neural Regen Res; 2019 Jul; 14(7):1158-1176. PubMed ID: 30804241 [TBL] [Abstract][Full Text] [Related]
39. Perspective Insights into Disease Progression, Diagnostics, and Therapeutic Approaches in Alzheimer's Disease: A Judicious Update. Jan AT; Azam M; Rahman S; Almigeiti AMS; Choi DH; Lee EJ; Haq QMR; Choi I Front Aging Neurosci; 2017; 9():356. PubMed ID: 29163138 [TBL] [Abstract][Full Text] [Related]